생명과학 툴, 시약 및 코로나19 진단 제품 시장 규모는 2023년 147억 달러, 2024년 130억 달러에서 예측 기간 동안 연평균 3.4% 성장하여 2029년 말에는 154억 달러 규모에 이를 것으로 예상됩니다.
생명과학 툴 및 시약 부문은 2024년 125억 달러에서 연평균 4.2% 성장하여 2029년 말에는 153억 달러에 달할 것으로 예상됩니다. 또한 생명과학의 코로나19 진단 제품 부문은 2024년 4억 7,960만 달러에서 연평균 42.8% 성장하여 2029년 말에는 2,940만 달러에 달할 것으로 예측됩니다.
유럽의 생명과학 툴 및 시약 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장 개요
개요
생명과학 부문 제품 개발
제3장 시장 역학
세계 시장 역학
시장 성장 촉진요인
시장 성장 억제요인
제4장 신기술과 개발
개요
차세대 치료제
차세대 진단약
디지털화
AI 및 머신러닝
IoT
생명과학 실험실 로봇
제5장 시장 세분화 분석
개요
세분화 내역
유럽의 생명과학 툴 및 시약 시장 : 제품 유형별
COVID-19 진단 검사 시장
생명과학 툴 및 시약 시장
유럽의 생명과학 툴 및 시약 시장 : 용도별
유전체학
단백질체학
세포생물학/항체/조합 단백질
줄기세포 연구
이미징 툴 및 기술
동물 모델
후성유전학
대사체학
기타
유럽
영국
독일
프랑스
스위스
스페인
이탈리아
기타
제6장 경쟁 정보
PCR 기술과 시약
항체
ELISA 기기
ELISA 키트 및 어세이
생명과학 키트 및 어세이
COVID-19 진단
전략적 이니셔티브
시장에서의 최근 제품 도입
제7장 유럽 생명과학 툴 및 시약 시장에서의 지속가능성 : ESG 관점
ESG : 서론
업계의 ESG 실천
업계의 ESG 현황
BCC의 결론
제8장 부록
조사 방법
두자어
출전
기업 개요
AGILENT TECHNOLOGIES INC.
ALTONA DIAGNOSTICS GMBH
ANALYTIK JENA GMBH+CO. KG
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY INC.
THERMO FISHER SCIENTIFIC INC.
LSH
영문 목차
영문목차
The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.
The European market for life science tools and reagents is expected to grow from $12.5 billion in 2024 to $15.3 billion by the end of 2029, at a CAGR of 4.2% from 2024 through 2029.
The European market for life science COVID-19 diagnostics products is expected to decline from $479.6 million in 2024 to $29.4 million by the end of 2029, at a negative CAGR of 42.8% from 2024 through 2029.
Report Scope
This report provides a comprehensive analysis of the European market for life science tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape, trends and market dynamics, such as drivers, restraints and opportunities. It also analyzes the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science tools included are hybridization systems, PCR, Western blotting instruments and ELISA instruments. The countries whose markets are analyzed are Germany, France, the U.K., Italy, Spain, Switzerland and the Rest of Europe. Markets are also analyzed by application.
Report Includes
33 data tables and 54 additional tables
An analysis of the European market for life science tools and reagents, including COVID-19 diagnostics products
Analyses of the market trends, with historic market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the market for life science tools and reagents, with market share analysis by product, application, and country
Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Merck KGaA, Qiagen and Roche
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Product Development in Life Science
Chapter 3 Market Dynamics
Global Market Dynamics
Market Drivers
Increasing Investments in R&D
Increasing Prevalence of Chronic Diseases
Increasing Demand for Various Diagnostics Pathways and In Vitro Diagnostics
Growth in Genomic and Biomarker Research
Increasing Demand for Personalized Medicine
Technological Advances
Market Restraints
End of COVID-19 Pandemic
High Cost of Instruments
Lack of Skilled Personnels
Market Challenges
Regulatory Hurdles
Market Opportunities
Positive Impact from Some Revisions in Pharmaceutical Legislation
New Technologies
Chapter 4 Emerging Technologies and Developments
Overview
Next-Generation Therapeutics
Next-Generation Diagnostics
Digitalization
AI and Machine Learning
Internet of Things (IoT)
Robots in Life Science Labs
Chapter 5 Market Segmentation Analysis
Overview
Segmentation Breakdown
European Market for Life Science Tools and Diagnostics, by Product Type
COVID-19 Diagnostic Tests Market
Market for Life Science Tools and Reagents
European Market for Life Science Tools and Diagnostics, by Application
Genomics
Proteomics
Cell Biology, Antibodies and Recombinant Proteins
Stem Cells Research
Imaging Tools and Techniques
Animal Models
Epigenetics
Metabolomics
Other Applications
Europe
United Kingdom
Germany
France
Switzerland
Spain
Italy
Rest of Europe
Chapter 6 Competitive Intelligence
PCR Technologies and Reagents
Antibodies
ELISA Instruments
ELISA Kits and Assays
Life Science Kits and Assays
COVID-19 Diagnostics
Strategic Initiatives
Recent Product Introductions in the Market
Chapter 7 Sustainability in Life Science Tools and Reagents in the European Market: An ESG Perspective
